Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DuPont (NYSE:DD) de Nemours Inc on Wednesday reported second-quarter 2023 adjusted earnings per share (EPS) of $0.85, surpassing the $0.83 FactSet consensus.    The chemicals company's revenue for the period, meanwhile, fell to $3.094 billion from $3.322 billion a year ago on weakness in construction end-markets, but still exceeded the $3.026 billion analyst consensus forecast.

DuPont 2Q earnings and revenue beat estimates; outlook disappoints

DuPont de Nemours (DD) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.88 per share a year ago.

DuPont de Nemours (DD) Q2 Earnings and Revenues Beat Estimates

DuPont de Nemours Inc.'s stock DD, -0.76% rose 1.3% premarket Wednesday, after the chemicals company topped forecasts for its second quarter earnings, although its guidance was mixed. The Wilmington, Del.-based company had a net loss of $131 million, or 84 cents a share, for the quarter, after income of $787 million, or 85 cents a share, in the year-earlier period.

DuPont's stock up 1.3% premarket as earnings beat offsets mixed guidance

Second Quarter 2023 Highlights Net Sales of $3.1 billion decreased 7%; organic sales decreased 4% versus year-ago period GAAP Income from continuing operations of $269 million; operating EBITDA of $738 million GAAP EPS from continuing operations of $0.55; adjusted EPS of $0.85 Cash provided by operating activities from continuing operations of $400 million; adjusted free cash flow of $277 million WILMINGTON, Del. , Aug. 2, 2023 /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the second quarter ended June 30, 2023.

DuPont Reports Second Quarter 2023 Results

WILMINGTON, Del. , Aug. 1, 2023 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has completed the previously announced acquisition of Spectrum Plastics Group ("Spectrum"), a recognized leader in specialty medical devices and components markets.

DuPont Completes Acquisition of Spectrum Plastics Group

WILMINGTON, Del. , July 18, 2023 /PRNewswire/ -- DuPont (NYSE: DD) will release its second quarter 2023 financial results at 6:00 a.m.

DuPont Schedules Second Quarter 2023 Earnings Conference Call

DuPont (DD) introduces FilmTec LiNE-XD nanofiltration membranes, enabling sustainable lithium extraction from diverse sources.

DuPont (DD) FilmTec LiNE-XD to Aid Sustainable Lithium Ouput

New FilmTec™ LiNE-XD nanofiltration membrane elements feature advanced membrane chemistry to support Direct Lithium Extraction (DLE) operations, which enable Lithium production from more sustainable and accessible sources  WILMINGTON, Del. , July 12, 2023 /PRNewswire/ -- DuPont (NYSE: DD) announced the commercial launch of the new DuPont™ FilmTec™ LiNE-XD nanofiltration membrane elements for lithium brine purification.

DuPont Launches First Nanofiltration Membrane Elements for High Productivity Lithium-Brine Purification

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continuing investigation whether certain directors and officers of DuPont de Nemours, Inc. (“DuPont”) (NYSE: DD) breached their fiduciary duties to DuPont and its shareholders. If you are a DuPont shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Investigates DuPont de Nemours, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DD

REGULATED INFORMATION                Paris, 5 July 2023 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION TOUAX: Half year statement of the liquidity contract with Gilbert Dupont stockbrockers   The liquidity account under the liquidity contract awarded by TOUAX SCA to Gilbert Dupont Stockbrokers, stood as follows on 30 June 2023: -        Number of shares: 11 754-        Cash in the liquidity account: 34 434,69 € During the first half of 2023, a total of: PURCHASE 54 698 shares 410 658,50 € 917 transactions SALE 55 742 shares 425 693,18 € 795 transactions was negotiated. For information, at the time of the half-year statement on 30 December 2022, the liquidity account had the following holdings: -        Number of TOUAX shares: 12 798-        Cash in the liquidity account: 19 400,01 € When setting up the contract, the liquidity account had the following holdings: -        Number of TOUAX shares: 0-        Cash in the liquidity account: €100,000.

TOUAX : Half-year statement of the liquidity contract with Gilbert Dupont stockbrockers

Blagnac, France, July 04th 2023-5.35pm Half-Yearly Statement H1 2023 relative to the liquidity contract placed with Société de Bourse GILBERT DUPONT In respect of the liquidity contract placed by SOGECLAIR with Société de Bourse Gilbert Dupont, as of 30 June 2023, the average liquidity account figures stood at: Number of shares: 1,704 Cash balance on the liquidity account: €35, 938.82 During the 1st half 2023, it has been trade a total of: PURCHASE 11,300 equities € 219,953.22 € 497 transactions SALE 12,347 equities € 241,978.15 € 456 transactions You are reminded that at the time of the yearly statement as of 31 December 2022, the average liquidity account figures stood at: Number of shares: 2,751 Cash balance on the liquidity account: €13,913.89 You are reminded that at the time of the setting up of the liquidity contract, the following means have been made available: Number of shares: 3,606 Cash balance on the liquidity account: €51,114.70 Philippe ROBARDEYPrésident SOGECLAIRSA with capital of €3,204,901Headquarters: 7 avenue Albert Durand – CS 20069 – 31700 BLAGNAC (France)Phone: 33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Attachment SOGECLAIR-Half yearly statement 2023

Sogeclair: Half-Yearly Statement H1 2023 relative to the liquidity contract placed with Société de Bourse GILBERT DUPONT

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of DuPont de Nemours, Inc. (“DuPont”) (NYSE: DD) breached their fiduciary duties to DuPont and its shareholders. If you are a DuPont shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com. Scott+Scott is investigating wh.

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates DuPont de Nemours, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DD

DuPont (DD) and JetCool tie up to establish a new sales channel for the latter's sophisticated cooling products in Taiwan and Singapore.

DuPont (DD) Partners With JetCool for High-Power Electronics

Use of Liquid Cooling Solutions in Semiconductor Advanced Packaging Applications Enables Efficient and Sustainable Thermal Management MARLBOROUGH, Mass. and LITTLETON, Mass.

DuPont and JetCool Announce Collaboration in Thermal Management for High-Power Electronics

DuPont's (DD) trusted product portfolio offers a wide range of performance advantages, from commercial aviation to space exploration and satellites.

DuPont (DD) Presents High-Performance Solutions at Paris Air Show

DuPont's diverse revenue streams and growing healthcare business make it a good long-term investment. Investors should wait for the stock to drop below $60 and yield 2.5% before buying. The company's focus on acquisitions and share buybacks may limit dividend growth.

DuPont de Nemours: Healthcare Offers Long-Term Growth

Lightweight and reliable products for mission-critical applications in aerospace, space exploration, and satellites Visit DuPont at Stand E64 in Hall 2B,  19-25 June 2023, Le Bourget, France LE BOURGET, France , June 19, 2023 /PRNewswire/ -- DuPont is showcasing solutions for the aerospace industry at the 54th International Paris Air Show, from 19 to 25 June 2023, at Le Bourget, just outside Paris. The company will feature a broad portfolio of aerospace solutions, including materials for space exploration and satellite applications.

DuPont Showcases High-Performance Solutions for Next-Generation Aerospace Technologies at 54th International Paris Air Show

Styrofoam™ Brand ST-100 Extruded Polystyrene Foam (XPS) Recognized in Environmental Protection Category WILMINGTON, Del. , June 8, 2023 /PRNewswire/ -- DuPont™ Styrofoam™ Brand ST-100 Extruded Polystyrene Foam (XPS) has received the 2023 ACC Sustainability Leadership Award in the Environmental Protection category.

DuPont Performance Building Solutions Receives 2023 American Chemistry Council (ACC) Sustainability Leadership Award

Advanced process solutions deliver reliability, performance, and sustainability advantages in traditional and emerging applications WILMINGTON, Del. , June 6, 2023 /PRNewswire/ -- DuPont (NYSE:DD) will showcase its novel process solutions for component finishing at SUR/FIN 2023, a conference and trade show dedicated specifically to the surface technology industry.

DuPont Introduces Novel Metallization and Finishing Solutions at SUR/FIN Show

DuPont (DD) benefits from healthy demand in water and general industrial, growth though innovation and pricing actions amid weakness in consumer electronics and semiconductor markets.

DuPont (DD) Gains on Productivity & Innovation, Destocking Ails

Chemours

Corteva Inc

The companies Chemours, DuPont and Corteva announced on Friday they have agreed to pay more than $1 billion to settle claims that "forever chemicals" contaminated public US water systems.

Three chemical giants agree to pay more than $1 billion to settle 'forever chemical' claims

3M faces a bellwether trial over PFAS, set to begin Monday, that could set the tone for future lawsuits.

States sue 3M, DuPont over toxic 'forever chemicals' found in drinking water

Dupont De Nemours Inc (NYSE:DD) stock is gapping higher today after news that the chemical name is joining Corteva (CTVA) and Chemours (CC) in setting up a $1.9 billion fund to settle multiple lawsuits over their alleged role in polluting drinking water in the U.S. with perfluoroalkyl and polyfluoroalkyl substances (PFAs).

Chemical Stock Pops on Billion-Dollar Settlement

Chemours Company, DuPont (NYSE:DD) de Nemours, Inc, and Corteva, Inc have jointly announced a settlement agreement in principle to comprehensively resolve all per and polyfluoroalkyl substances (PFAS)-related drinking water claims of a defined class of public water systems that serve the vast majority of the US population. Shares of Chemours soared 25% to $33.93, while DuPont stock rose 6% to $71.60 and Corteva shares gained 3% to $55.30 in Friday morning trading.

Chemours, DuPont, and Corteva shares rally after settlement deal in drinking water claims

DALLAS--(BUSINESS WIRE)--Baron & Budd is proud to announce that DuPont has agreed to pay $1.185 billion to public water systems across the United States that detect PFAS chemicals in their drinking water supplies. The lawsuits allege that DuPont and several other manufacturers sold PFAS-containing products when the companies knew that PFAS compounds would readily contaminate the environment and have the potential to cause human health problems including cancers. Per- and polyfluoroalkyl sub.

News for DuPont de Nemours Stock (DD)